ATC code G
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
(Redirected from ATCvet code QG)
Pharmaceutical drug classification
ATC code G: Genito-urinary system and sex hormones |
---|
|
ATCvet only |
|
Other ATC codes |
ATC code G Genito-urinary system and sex hormones is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QG.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code G". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QG". WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
---|---|
gastrointestinal tract / metabolism (A) | |
blood and blood forming organs (B) | |
cardiovascular system (C) | |
skin (D) | |
genitourinary system (G) | |
endocrine system (H) | |
infections and infestations (J, P, QI) | |
malignant disease (L01–L02) | |
immune disease (L03–L04) | |
muscles, bones, and joints (M) | |
brain and nervous system (N) |
|
respiratory system (R) | |
sensory organs (S) | |
other ATC (V) | |
Antibiotics | |||||||||
---|---|---|---|---|---|---|---|---|---|
Arsenic compounds | |||||||||
Quinoline derivatives | |||||||||
Organic acids | |||||||||
Sulfonamides | |||||||||
Antifungals |
| ||||||||
Other |
Cervical ripening |
| ||||
---|---|---|---|---|---|
Contraction induction | |||||
|
Birth control methods | |||||||
---|---|---|---|---|---|---|---|
Related topics | |||||||
Long-acting reversible contraception (LARC) | |||||||
Sterilization |
| ||||||
Hormonal contraception |
| ||||||
Barrier Methods | |||||||
Emergency Contraception (Post-intercourse) | |||||||
Spermicides | |||||||
Behavioral |
| ||||||
Experimental |
Tocolytics/labor repressants (G02CA) | |
---|---|
β2 adrenoreceptor agonists | |
Oxytocin antagonists | |
NSAIDs | |
Calcium channel blockers | |
Myosin inhibitors |
Prolactin inhibitors | |
---|---|
Anti-inflammatory products for vaginal administration |
Estrogens |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Antiestrogens |
| ||||||||
|
Progestogens (and progestins) |
| ||||
---|---|---|---|---|---|
Antiprogestogens |
| ||||
|
GnRH modulators (incl. analogues) |
| ||||
---|---|---|---|---|---|
Gonadotropins |
| ||||
Others (indirect) |
| ||||
|
Urologicals, including antispasmodics (G04B) | |
---|---|
Acidifiers | |
Urinary antispasmodics (primarily antimuscarinics) | |
Other urologicals |
For erectile dysfunction |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
For premature ejaculation |
| ||||||||||||
|